GMDA
Gamida Cell Ltd
Price:  
0.03 
USD
Volume:  
23,036,900.00
Israel | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GMDA WACC - Weighted Average Cost of Capital

The WACC of Gamida Cell Ltd (GMDA) is 6.8%.

The Cost of Equity of Gamida Cell Ltd (GMDA) is 38.35%.
The Cost of Debt of Gamida Cell Ltd (GMDA) is 7.00%.

Range Selected
Cost of equity 32.30% - 44.40% 38.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.5% - 7.1% 6.8%
WACC

GMDA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 6.18 7.05
Additional risk adjustments 0.0% 0.5%
Cost of equity 32.30% 44.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 19.07 19.07
Cost of debt 7.00% 7.00%
After-tax WACC 6.5% 7.1%
Selected WACC 6.8%

GMDA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for GMDA:

cost_of_equity (38.35%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (6.18) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.